Our selected combination of L30I40 synergistically inhibited cell proliferation only in ER+ breast cancer MCF7 and T47D cells, not in TNBC BT-549 and MDA-MB-231 cells, suggesting that this synergistic inhibitory effect requires the ERα pathway. The gene discussed is ESR1; the disease is breast carcinoma.